Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-0497-2013

Medtronic SynchroMed II, Model 8637, (The SynchroMed® II Pump is supplied in 20 ml or 40 ml reservoir size.) Sterilized using ethylene oxide. The pump is part of an infusion system that stores and delivers a prescribed drug to a specific site. The implantable components of the SynchroMed II Infusion System include the pump, catheter, and catheter accessories.

Publicado el 19 de diciembre de 2012 · Inicio del retiro: 9 de noviembre de 2012

Resumen

FDA registra el retiro Z-0497-2013 de dispositivos médicos de Clase I, publicado el 19 de diciembre de 2012 e iniciado el 9 de noviembre de 2012. Empresa responsable: Medtronic Neuromodulation; Estado: Finalizado; Cantidad reportada: 174,700 devices total; Lote: All SynchroMed EL and SynchroMed II pumps. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Medtronic notified Healthcare Professionals of the impact of unapproved drugs on the performance of the SynchroMed infusion pump system. Use of unapproved drugs with SynchroMed pumps can result in an increased risk of permanent motor stall and cessation of drug infusion. UPDATE 2/1/2016: Medtronic received approval to incorporate enhancements to the SynchroMed II pump which decreases the potential for internal electrical shorting and motor corrosion, and is retrieving any unused pumps.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Medtronic Neuromodulation
Distribuidor
Worldwide distribution: USA (nationwide) and countries including: Canada and Mexico.
Lote
All SynchroMed EL and SynchroMed II pumps
Clasificación de riesgo
Class I
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Medtronic SynchroMed II, Model 8637, (The SynchroMed® II Pump is supplied in 20 ml or 40 ml reservoir size.) Sterilized using ethylene oxide. The pump is part of an infusion system that stores and delivers a prescribed drug to a specific site. The implantable components of the SynchroMed II Infusion System include the pump, catheter, and catheter accessories. fue retirado del mercado?

Sí. FDA publicó el retiro Z-0497-2013 el 19 de diciembre de 2012. Peligro reportado: Medtronic notified Healthcare Professionals of the impact of unapproved drugs on the performance of the SynchroMed infusion pump system. Use of unapproved drugs with SynchroMed pumps can result in an increased risk of permanent motor stall and cessation of drug infusion. UPDATE 2/1/2016: Medtronic received approval to incorporate enhancements to the SynchroMed II pump which decreases the potential for internal electrical shorting and motor corrosion, and is retrieving any unused pumps.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter